• 

  May 13, 2026

  CTIBIOTECH Lands €1.25M from France 2030 to Industrialize 3D Bioprinted Tumors, and Take Aim at Oncology’s 95% Failure Problem

  R.D. Solorzano

• 

  May 8, 2026

  restor3d’s Aeros Ankle System Goes Full Commercial, 3D-Printed Orthopaedics Hits the Clinic

  R.D. Solorzano

• 

  May 7, 2026

  Miromatrix’s miroliverELAP Earns RMAT Designation

  R.D. Solorzano

• 

  May 2, 2026

  Hyalex Secures 510(k) Clearance for Cartilage-Mimicking Implant, Advancing Synthetic Biomaterials into Market

  R.D. Solorzano

• 

  May 1, 2026

  XellSmart Launches Phase II Trial of Off-the-Shelf iPSC Cell Therapy for Parkinson’s

  R.D. Solorzano

• 

  April 30, 2026

  Eli Lilly Pays Up to $7B for Kelonia’s In Vivo CAR-T Platform and What It Means for Cell Therapy Manufacturing

  R.D. Solorzano

• 

  April 29, 2026

  OHSU Secures $9.2M NIH Grant to Advance Bone Cancer Organs-on-Chips Research

  R.D. Solorzano

• 

  April 24, 2026

  Linton Lifesciences Launches Biofabricated NAMs: Rebuilding the Missing Layer Between Biology and Decision-Making

  R.D. Solorzano

• 

  April 21, 2026

  ARPA-H Is Funding the Regeneration of Human Joints, and the Biofabrication Implications Go Further Than Osteoarthritis

  R.D. Solorzano

• 

  April 9, 2026

  The $150 Bioprinter Extruder That Anyone Can Build

  R.D. Solorzano